Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

NCT05782777 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05782777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05782777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Recruiting
Start date
April 7, 2023
Completion date
December 31, 2027
Enrollment
4,310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease requiring coronary revascularization with newer generation des implantation